JSI Research Chemicals
Portland, United States· Est.
A full‑service CRO and custom‑synthesis partner accelerating drug discovery for Alzheimer’s, cancer, and flaviviral diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A full‑service CRO and custom‑synthesis partner accelerating drug discovery for Alzheimer’s, cancer, and flaviviral diseases.
Alzheimer's diseaseOncologyFlaviviral diseases
Technology Platform
Integrated custom synthesis and analytical services leveraging modern organic chemistry, isotope labeling, and advanced LC‑MS/NMR/HPLC platforms for rapid drug discovery and process development.
Opportunities
Expansion into U.S.
and European markets and growing demand for integrated, cost‑effective early‑stage drug development services in neurodegeneration and viral therapeutics.
Risk Factors
Reliance on a limited client pool, regulatory compliance for manufacturing, and intense competition from larger, well‑funded CROs.
Competitive Landscape
Competes with global CROs like Charles River and WuXi AppTec; differentiates through a vertically integrated, sustainability‑focused service model that consolidates discovery, analytics, and scale‑up.